14028 injection (dulaglutide biosimilar)
/ Sunshine Lake Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
August 25, 2022
A Pharmacokinetic Study Comparing the 14028 Injection and TRULICITY® in Healthy Chinese Subjects
(clinicaltrials.gov)
- P1 | N=68 | Completed | Sponsor: Sunshine Lake Pharma Co., Ltd. | Recruiting ➔ Completed
Trial completion • Diabetes • Metabolic Disorders • Type 2 Diabetes Mellitus
July 14, 2022
A Pharmacokinetic Study Comparing the 14028 Injection and TRULICITY® in Healthy Chinese Subjects
(clinicaltrials.gov)
- P1 | N=68 | Recruiting | Sponsor: Sunshine Lake Pharma Co., Ltd.
New P1 trial • Diabetes • Metabolic Disorders • Type 2 Diabetes Mellitus
1 to 2
Of
2
Go to page
1